Magnetic properties of the spin-1 chain compound NiCl3_3C6_6H5_5CH2_2CH2_2NH3_3

We report experimental results of the static magnetization, ESR and NMR spectroscopic measurements of the Ni-hybrid compound NiCl$_3$C$_6$H$_5$CH$_2$CH$_2$NH$_3$. In this material NiCl$_3$ octahedra are structurally arranged in chains along the crystallographic $a$-axis. According to the static susceptibility and ESR data Ni$^{2+}$ spins $S = 1$ are isotropic and are coupled antiferromagnetically (AFM) along the chain with the exchange constant $J = 25.5$ K. These are important prerequisites for the realization of the so-called Haldane spin-1 chain with the spin-singlet ground state and a quantum spin gap. However, experimental results evidence AFM order at $T_{\rm N} \approx 10$ K presumably due to small interchain couplings. Interestingly, frequency-, magnetic field-, and temperature-dependent ESR measurements, as well as the NMR data, reveal signatures which could presumably indicate an inhomogeneous ground state of co-existent mesoscopically spatially separated AFM ordered and spin-singlet state regions similar to the situation observed before in some spin-diluted Haldane magnets

Cover to Volume 3

The fibroblast mitogen platelet-derived growth factor -BB (PDGF-BB) induces a transient expression of the orphan nuclear receptor NR4A1 (also named Nur77, TR3 or NGFIB). The aim of the present study was to investigate the pathways through which NR4A1 is induced by PDGF-BB and its functional role. We demonstrate that in PDGF-BB stimulated NIH3T3 cells, the MEK1/2 inhibitor CI-1040 strongly represses NR4A1 expression, whereas Erk5 downregulation delays the expression, but does not block it. Moreover, we report that treatment with the NF-κB inhibitor BAY11-7082 suppresses NR4A1 mRNA and protein expression. The majority of NR4A1 in NIH3T3 was found to be localized in the cytoplasm and only a fraction was translocated to the nucleus after continued PDGF-BB treatment. Silencing NR4A1 slightly increased the proliferation rate of NIH3T3 cells; however, it did not affect the chemotactic or survival abilities conferred by PDGF-BB. Moreover, overexpression of NR4A1 promoted anchorage-independent growth of NIH3T3 cells and the glioblastoma cell lines U-105MG and U-251MG. Thus, whereas NR4A1, induced by PDGF-BB, suppresses cell growth on a solid surface, it increases anchorage-independent growth

Thermochromic effects in a Jahn-Teller active CuCl64- layered hybrid system

<p>The hybrid material copper (II) tetrachloro-bis(phenyl ethyl ammonium) (C6H5CH2CH2NH3 )(2)CuCl4, or PEACuCl, has been investigated by temperature-dependent spectroscopic absorption experiments. The absorption bands observed in the near-infrared region (1.3-1.9 eV) generally exhibit redshifts with increasing temperature. The temperature-induced energy shifts of the spectral components are shown to be consistently related to temperature-induced Cu-Cl bond length changes. Additionally, the thermochromic color change is caused by a charge transfer band edge redshifting (in the visible region 2.0-2.8 eV) with increasing temperature. By comparison with similar Cu-based systems, it is suggested that this shift is caused by broadening and strengthening of the band.</p>

Degradation of the endothelial glycocalyx is associated with chylomicron leakage in mouse cremaster muscle microcirculation

A thick endothelial glycocalyx contributes to the barrier function of vascular endothelium in macro- and microcirculation. We hypothesised in the current study that diet-induced hyperlipidaemia perturbs the glycocalyx, resulting in decreased dimensions of this layer and increased transendothelial lipoprotein leakage in capillaries. Glycocalyx thickness was measured in mouse cremaster muscle capillaries by intravital microscopy from the distance between flowing red blood cells and the endothelial surface. In control C57BL/6 mice on standard chow, glycocalyx thickness measured 0.58 +/- 0.01 (mean +/- SEM) mu m, and no lipoproteins were observed in the tissue. After three months administration of an either mild or severe high-fat / high-cholesterol diet (HFC) to C57BL/6 and ApoE3-Leiden mice, circulating large lipoproteins appeared into the subendothelial space in an increasing proportion of cremaster capillaries, and these capillaries displayed reduced glycocalyx dimensions of 0.40 +/- 0.02 and 0.30 +/- 0.01 mu m (C57BL/6 mice), and 0.37 +/- 0.01 and 0.28 +/- 0.01 mu m (ApoE3-Leiden mice), after the mild and severe HFC diet, respectively. The chylomicron nature of the accumulated lipoproteins was confirmed by observations of subendothelial deposition of Dil-labeled chylomicrons in capillaries after inducing acute glycocalyx degradation by heparitinase in normolipidaemic C57BL/6 mice. It is concluded that while under control conditions the endothelial glycocalyx contributes to the vascular barrier against trans-vascular lipoprotein leakage in the microcirculation, diet-induced hyperlipidaemia reduces the thickness of the glycocalyx, thereby facilitating leakage of chylomicrons across the capillary wal

Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry

Contains fulltext : 176952.pdf (publisher's version ) (Open Access)OBJECTIVE: The dual-therapy stent combines an abluminal biodegradable drug-eluting coating, with a 'pro-healing' luminal layer. This bioengineered layer attracts circulating endothelial progenitor cells that can differentiate into normal endothelium. Rapid endothelialisation of the stent might allow safe short dual antiplatelet therapy. We aim to assess clinical outcomes in patients treated with this novel device at 2-year follow-up. METHODS: A total of 1000 patients were included in the REMEDEE Registry to evaluate clinical outcomes after treatment with the dual-therapy stent. This prospective, multicentre, European registry included all-comers patients, which resulted in a high-risk patient population. Target lesion failure (TLF), a combined endpoint consisting of cardiac death, target vessel myocardial infarction (tv-MI) and target lesion revascularisation (TLR), at 2-year follow-up was the primary focus of this analysis. Subgroup analyses were performed according to diabetes mellitus (DM), gender, age, acute coronary syndrome, smoking, hypertension, hypercholesterolaemia, previous stroke, peripheral vascular disease and chronic renal failure. RESULTS: TLF at 2 years was observed in 84 patients (8.5%), with 3.0% cardiac death, 1.2% tv-MI and 5.9% TLR. Definite stent thrombosis at 2 years was 0.6%. In the presence of DM or chronic renal failure, a higher TLF was observed. CONCLUSIONS: The dual-therapy stent shows favourable clinical outcomes from 12 months onwards. Two years after stent placement, low TLF and very low stent thrombosis rates are observed in this large prospective all-comers cohort study. TRIAL REGISTRATION NUMBER: NCT01874002; Results

Magnetic properties of the spin-1 chain compound NiCl₃C₆H₅CH₂CH₂NH₃

We report experimental results of the static magnetization, ESR and NMR spectroscopic measurements of the Ni-hybrid compound NiCl₃C₆H₅CH₂CH₂NH₃. In this material NiCl₃ octahedra are structurally arranged in chains along the crystallographic a axis. According to the static susceptibility and ESR data Ni²⁺ spins S = 1 are isotropic and are coupled antiferromagnetically (AFM) along the chain with the exchange constant J = 25.5 K. These are important prerequisites for the realization of the so-called Haldane spin-1 chain with the spin-singlet ground state and a quantum spin gap. However, experimental results evidence AFM order at TN ≈ 10 K presumably due to small interchain couplings. Interestingly, frequency-, magnetic field-, and temperature-dependent ESR measurements, as well as the NMR data, reveal signatures which could presumably indicate an inhomogeneous ground state of co-existent mesoscopically spatially separated AFM ordered and spin-singlet state regions similar to the situation observed before in some spin-diluted Haldane magnets

TCT-68 One Year Clinical Outcomes in Patients with Insulin-Treated Diabetes Mellitus and Non-Insulin-Treated Diabetes Mellitus Compared to Non-Diabetics after Deployment of the Abluminal Sirolimus Coated Bio-Engineered (COMBO) Stent in an All-Comers Registry

Item does not contain fulltex

TCT-470 Two Year Clinical Results after Deployment of the Abluminal Sirolimus Coated Bio-Engineered (COMBO) Stent in a Thousand Patient All-Comers Registry

Item does not contain fulltex